|
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study |
|
|
|
Title: |
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study |
Author: |
Kelley, R.K. Verslype, C. Cohn, A.L. Yang, T.-S. Su, W.-C. Burris, H. Braiteh, F. Vogelzang, N. Spira, A. Foster, P. Lee, Y. Van Cutsem, E. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 28 () nr. 3 pages 528-534 |
Year: |
2017 |
Contents: |
|
Publisher: |
THE AUTHORS |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|